首页 | 本学科首页   官方微博 | 高级检索  
     

经静脉尿激酶溶栓在治疗门静脉高压症脾切除术后门静脉血栓的疗效观察
引用本文:伏志,王鑫,张媛媛,张静,王璐,吴晓峰,臧运金,林栋栋. 经静脉尿激酶溶栓在治疗门静脉高压症脾切除术后门静脉血栓的疗效观察[J]. 医学研究杂志, 2015, 44(7): 107-109
作者姓名:伏志  王鑫  张媛媛  张静  王璐  吴晓峰  臧运金  林栋栋
作者单位:100069,首都医科大学附属北京佑安医院肝移植中心
摘    要:
目的:评价经静脉尿激酶溶栓在治疗门静脉高压症脾切除术后门静脉血栓( PVT)的效果。方法回顾性研究63例脾切除贲门周围血管离断术后发生PVT患者,分别给予抗凝、祛聚治疗及溶栓治疗,比较两组患者的一般情况及PVT治疗效果。结果两组患者的一般情况比较,差异无统计学意义(P>0.05),PVT治疗效果,溶栓组治疗有效率显著高于抗凝、祛聚组( P<0.01)。结论对于脾切除术后预防性应用抗凝、祛聚治疗仍发生PVT的患者,经静脉应用尿激酶溶栓治疗作为一种补救性治疗手段,可取得较好效果,且方法相对简便,可行性强,较少发生严重并发症。

关 键 词:脾切除  门静脉血栓  溶栓治疗
收稿时间:2015-03-14
修稿时间:2015-03-26

Effect of Intravenous Urokinase Thrombolysis in the Treatment of Portal Vein Thrombosis(PVT) after Splenectomy
Fu Zhi,Wang Xin,Zhang Yuanyuan. Effect of Intravenous Urokinase Thrombolysis in the Treatment of Portal Vein Thrombosis(PVT) after Splenectomy[J]. Journal of Medical Research, 2015, 44(7): 107-109
Authors:Fu Zhi  Wang Xin  Zhang Yuanyuan
Affiliation:Liver Transplantation Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;Liver Transplantation Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;Liver Transplantation Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;Liver Transplantation Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;Liver Transplantation Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;Liver Transplantation Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;Liver Transplantation Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;Liver Transplantation Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China
Abstract:
Objective To evaluate the effect of intravenous urokinase thrombolysis in the treatment of portal vein thrombosis(PVT) after splenectomy. Methods Sixty three PVT patients were included into the retrospective study and devided into two groups according to anticoagulation therapy or thrombolytic therapy. The general condition and effect of treatment were compared. Results There was no significant difference in the general situation of two groups of patients (P>0.05). The efficiency of thrombolytic treatment group was significantly higher than anticoagulation group (P<0.01). Conclusion Intravenous urokinase thrombolysis in the treatment of portal vein thrombosis(PVT) after splenectomy is effectiye and safe.
Keywords:Splenectomy  Portal vein thrombosis  Thrombolytic therapy
点击此处可从《医学研究杂志》浏览原始摘要信息
点击此处可从《医学研究杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号